BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Perrot M, Wu L, Cabanero M, Perentes JY, McKee TD, Donahoe L, Bradbury P, Kohno M, Chan ML, Murakami J, Keshavjee S, Tsao MS, Cho BCJ. Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma. J Thorac Cardiovasc Surg 2020;159:2082-2091.e1. [PMID: 31866087 DOI: 10.1016/j.jtcvs.2019.10.122] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Kohno M, Murakami J, Wu L, Chan ML, Yun Z, Cho BCJ, de Perrot M. Foxp3+ Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma. J Immunol 2020;205:2519-31. [PMID: 32948683 DOI: 10.4049/jimmunol.2000487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Fusco N, Vaira V, Righi I, Sajjadi E, Venetis K, Lopez G, Cattaneo M, Castellani M, Rosso L, Nosotti M, Clerici M, Ferrero S. Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients. Lung Cancer 2020;150:53-61. [PMID: 33065463 DOI: 10.1016/j.lungcan.2020.09.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
3 Pass HI. Commentary: Not only SMART clinically, but translationally! The Journal of Thoracic and Cardiovascular Surgery 2020;159:2094-5. [DOI: 10.1016/j.jtcvs.2019.09.101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Waller DA, Opitz I, Bueno R, Van Schil P, Cardillo G, Harpole D, Adusumilli PS, De Perrot M. Divided by an ocean of water but united in an ocean of uncertainty: A transatlantic review of mesothelioma surgery guidelines. J Thorac Cardiovasc Surg 2021;161:1922-5. [PMID: 33223192 DOI: 10.1016/j.jtcvs.2020.11.001] [Reference Citation Analysis]
5 Wu L, Amjad S, Yun H, Mani S, de Perrot M. A panel of emerging EMT genes identified in malignant mesothelioma. Sci Rep 2022;12:1007. [PMID: 35046456 DOI: 10.1038/s41598-022-04973-x] [Reference Citation Analysis]
6 Jin L, Gu W, Li X, Xie L, Wang L, Chen Z. PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study. Ther Adv Med Oncol 2020;12:1758835920962362. [PMID: 33062064 DOI: 10.1177/1758835920962362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Donahoe LL, de Perrot M. The Role of Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma. Thoracic Surgery Clinics 2020;30:461-71. [DOI: 10.1016/j.thorsurg.2020.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen-Yoshikawa TF. Commentary: A journey of a thousand miles begins with a single step. J Thorac Cardiovasc Surg 2020;159:2092-3. [PMID: 31627947 DOI: 10.1016/j.jtcvs.2019.09.040] [Reference Citation Analysis]
9 Pass HI. SMART: logical radiotherapy and surgery beyond MARS. Lancet Oncol 2021;22:156-7. [PMID: 33450183 DOI: 10.1016/S1470-2045(20)30672-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Murakami J, Wu L, Kohno M, Chan ML, Zhao Y, Yun Z, Cho BCJ, de Perrot M. Triple-modality therapy maximizes antitumor immune responses in a mouse model of mesothelioma. Sci Transl Med 2021;13:eabd9882. [PMID: 33853932 DOI: 10.1126/scitranslmed.abd9882] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lanuti M, Lin J, Ng T, Burt BM. A year in general thoracic surgery published in the Journal of Thoracic and Cardiovascular Surgery: 2020. J Thorac Cardiovasc Surg 2021;162:253-8. [PMID: 34024614 DOI: 10.1016/j.jtcvs.2021.03.106] [Reference Citation Analysis]
12 Napoli F, Listì A, Zambelli V, Witel G, Bironzo P, Papotti M, Volante M, Scagliotti G, Righi L. Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma. Cancers (Basel) 2021;13:2564. [PMID: 34073720 DOI: 10.3390/cancers13112564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Rosenzweig KE. Radiation Therapy for Malignant Pleural Mesothelioma. Thorac Surg Clin 2020;30:473-80. [PMID: 33012434 DOI: 10.1016/j.thorsurg.2020.08.006] [Reference Citation Analysis]
14 Waller DA, Opitz I, Bueno R, Van Schil P, Cardillo G, Harpole D, Adusumilli PS, De Perrot M. Divided by an ocean of water but united in an ocean of uncertainty: a transatlantic review of mesothelioma surgery guidelines. Eur J Cardiothorac Surg 2021;59:8-11. [PMID: 33395697 DOI: 10.1093/ejcts/ezaa363] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cho BCJ, Donahoe L, Bradbury PA, Leighl N, Keshavjee S, Hope A, Pal P, Cabanero M, Czarnecka K, McRae K, Tsao MS, de Perrot M. Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial. Lancet Oncol 2021;22:190-7. [PMID: 33450184 DOI: 10.1016/S1470-2045(20)30606-9] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Chan M, Wu L, Yun Z, McKee TD, Cabanero M, Zhao Y, Kohno M, Murakami J, de Perrot M. Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma. Commun Biol 2021;4:914. [PMID: 34312483 DOI: 10.1038/s42003-021-02430-5] [Reference Citation Analysis]
17 Waller DA, Opitz I, Bueno R, Van Schil P, Cardillo G, Harpole D, Adusumilli PS, De Perrot M. Divided by an Ocean of Water but United in an Ocean of Uncertainty: A Transatlantic Review of Mesothelioma Surgery Guidelines. Ann Thorac Surg 2021;111:386-9. [PMID: 33223138 DOI: 10.1016/j.athoracsur.2020.10.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]